Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Limb-Girdle Muscular Dystrophies”

80 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 80 results

Testing effectiveness (Phase 2)Study completedNCT02579239
What this trial is testing

Evaluate Safety and Biological Activity of ATYR1940 in Participants With Limb Girdle Muscular Dystrophy 2B (LGMD2B) and Facioscapulohumeral Muscular Dystrophy (FSHD)

Who this might be right for
Limb-Girdle Muscular DystrophiesFacioscapulohumeral Muscular Dystrophy
aTyr Pharma, Inc. 18
Not applicableLooking for participantsNCT00313677
What this trial is testing

Clinical Trial Readiness for the Dystroglycanopathies

Who this might be right for
Muscular Dystrophy
Katherine Mathews 190
Not applicableUnknownNCT01740908
What this trial is testing

Stem Cell Quantification In Peripheral Blood After Hyperbaric Oxygen Therapy Treatments

Who this might be right for
Changes in Peripheral Blood Population Numbers and Type.
Restorix Research Institute, LLLP 8
Large-scale testing (Phase 3)Ended earlyNCT03783923
What this trial is testing

Deflazacort (Emflaza®) in Participants With Limb-Girdle Muscular Dystrophy 2I (LGMD2I)

Who this might be right for
Limb-Girdle Muscular Dystrophy
PTC Therapeutics 11
Early research (Phase 1)Ended earlyNCT05906251
What this trial is testing

A Gene Transfer Study to Evaluate the Safety, Tolerability and Efficacy of SRP-6004 in Ambulatory Participants With Limb Girdle Muscular Dystrophy, Type 2B/R2 (LGMD2B/R2, Dysferlin [DYSF] Related)

Who this might be right for
Limb Girdle Muscular Dystrophy
Sarepta Therapeutics, Inc. 2
Not applicableStudy completedNCT03981289
What this trial is testing

Defining Clinical Endpoints in Limb Girdle Muscular Dystrophy (LGMD)

Who this might be right for
Limb Girdle Muscular DystrophyMuscular Dystrophies
Virginia Commonwealth University 116
Not applicableStudy completedNCT03488784
What this trial is testing

Natural History of Limb Girdle Muscular Dystrophy Type 2A and Type 2E

Who this might be right for
Limb-Girdle Muscular Dystrophy Type 2ALimb-Girdle Muscular Dystrophy, Type 2E
Lindsay Alfano 100
Testing effectiveness (Phase 2)Ended earlyNCT03652259
What this trial is testing

Gene Delivery Clinical Trial of SRP-9003 (Bidridistrogene Xeboparvovec) for Participants With Limb-Girdle Muscular Dystrophy, Type 2E (LGMD2E) (Beta-Sarcoglycan Deficiency)

Who this might be right for
Limb-Girdle Muscular Dystrophy, Type 2E
Sarepta Therapeutics, Inc. 6
Not applicableUnknownNCT04772027
What this trial is testing

Motor Parameters in Patients With Limb Girdle Muscular Dystrophy

Who this might be right for
Limb Girdle Muscular Dystrophies
Assistance Publique - Hôpitaux de Paris 80
Not applicableEnded earlyNCT05528757
What this trial is testing

Limb-Girdle Video Assessment

Who this might be right for
Limb-Girdle Muscular Dystrophy ; Subtypes 2A, 2B, and 2I
The Emmes Company, LLC 45
Large-scale testing (Phase 3)WithdrawnNCT06952686
What this trial is testing

SRP-9005 in Limb Girdle Muscular Dystrophy Type 2C/R5 Pediatric and Adult Participants

Who this might be right for
Muscular Dystrophies, Limb-Girdle
Sarepta Therapeutics, Inc.
Not applicableLooking for participantsNCT05902351
What this trial is testing

Natural History Study for Charcot Marie Tooth Disease

Who this might be right for
Charcot-Marie-Tooth DiseaseCharcot-Marie-ToothCharcot-Marie-Tooth Disease, Type IA+45 more
Hereditary Neuropathy Foundation 10,000
Not applicableUnknownNCT01676077
What this trial is testing

Clinical Outcome Study for Dysferlinopathy

Who this might be right for
DysferlinopathyLGMD2B Now Classified as LGMDR2Miyoshi Myopathy
Newcastle-upon-Tyne Hospitals NHS Trust 200
Not applicableStudy completedNCT01783509
What this trial is testing

Limb Girdle Muscular Dystrophy (LGMD) Natural History

Who this might be right for
Muscular Dystrophies, Limb-Girdle (GENETICALLY CONFIRMED)
Wake Forest University Health Sciences 13
Early research (Phase 1)Study completedNCT05286281
What this trial is testing

Evaluate The Pharmacokinetics, Excretion, Mass Balance and Metabolism of PF-07265803

Who this might be right for
Healthy
Pfizer 6
Large-scale testing (Phase 3)Ended earlyNCT03439514
What this trial is testing

ARRY-371797 (PF-07265803) in Patients With Symptomatic Dilated Cardiomyopathy Due to a Lamin A/C Gene Mutation

Who this might be right for
Dilated CardiomyopathyLamin A/C Gene Mutation
Pfizer 77
Early research (Phase 1)Study completedNCT02710500
What this trial is testing

RAAVrh74.MHCK7.DYSF.DV for Treatment of Dysferlinopathies

Who this might be right for
Dysferlinopathy
Sarepta Therapeutics, Inc. 2
Not applicableWithdrawnNCT05952388
What this trial is testing

Impact of Clinical Pharmacy Services on Medication Cost and Hospitalization Rates in Hemodialysis Patients

Who this might be right for
End Stage Renal Disease
University of New Mexico
Not applicableStudy completedNCT00785005
What this trial is testing

What Makes Exercise Feel More Difficult to Women With and Without Type 2 Diabetes

Who this might be right for
Type 2 Diabetes
University of Colorado, Denver 99
Large-scale testing (Phase 3)Active Not RecruitingNCT06246513
What this trial is testing

A Trial to Learn More About an Experimental Gene Therapy Called Bidridistrogene Xeboparvovec (SRP-9003) as a Possible Treatment for Limb Girdle Muscular Dystrophy 2E/R4

Who this might be right for
Limb-girdle Muscular Dystrophy
Sarepta Therapeutics, Inc. 17
Load More Results